Surveillance and vaccine effectiveness of pertussis, the Netherlands, 2012 to 2024, with an unprecedented surge in 2023 and 2024.

Publication date: Apr 01, 2026

BACKGROUNDA surge in pertussis occurred in the Netherlands in 2023-24. Infant vaccination uptake decreased from 95% in 2011 to ca 86% in 2024. Maternal vaccination was introduced in 2019, with uptake ca 70%. AIMTo describe pertussis epidemiological trends in the Netherlands. METHODSWe conducted a retrospective study using pertussis notification data from 2012 to 2024 and estimated infant and maternal vaccine effectiveness (VE) with the screening method. RESULTSDuring the COVID-19 pandemic, pertussis notifications dropped from ca 6,000 in 2013-19 to 79 in 2021 (incidence ca 35 to

Concepts Keywords
Netherlands Adolescent
Pandemic Adult
Vaccination Child
Child, Preschool
COVID-19
Disease Notification
Disease outbreaks
Female
Humans
Incidence
Infant
Infant, Newborn
Male
maternally-acquired immunity
Middle Aged
Netherlands
Pertussis
Pertussis Vaccine
Pertussis Vaccine
Population Surveillance
Retrospective Studies
Surveillance
Vaccination
Vaccination
Vaccine effectiveness
Vaccine Efficacy
Whooping Cough
Whooping cough
Young Adult

Semantics

Type Source Name
disease MESH pertussis
pathway KEGG Pertussis
disease MESH COVID-19 pandemic

Original Article

(Visited 7 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *